Clinical Trial Update: An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating memantine for safety and efficacy in agitated patients with moderate to severe Alzheimer's disease has completed. The sponsor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Forest Laboratories | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED